Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $83,556 - $264,758
3,798 New
3,798 $254,000
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $164,377 - $409,798
-12,060 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$16.12 - $24.98 $194,407 - $301,258
12,060 New
12,060 $288,000
Q4 2017

Feb 14, 2018

SELL
$26.43 - $31.78 $433,769 - $521,573
-16,412 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $190,543 - $512,218
16,412
16,412 $512,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.